Qaialdo
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Qaialdo, covering 2026-03-24 to 2026-07-14. Get the full timeline:
Most recent: EMA Authorised: Qaialdo (spironolactone) — Lipomed GmbH
2 regulatory and trial events tracked for Qaialdo, covering 2026-03-24 to 2026-07-14. Get the full timeline:
Most recent: EMA Authorised: Qaialdo (spironolactone) — Lipomed GmbH